Chemical and MaterialsNews

Lyme Disease Drug Market is Booming Market Growing by 2026 with Top Key Players Sandoz International GmbH, Abbott, F. Hoffmann-La Roche, Canon U.S.A., T2 Biosystems, Lupin Pharmaceuticals

Global Lyme Disease Drug Market

Lyme disease is a serious infection caused by Borrelia burgdorferi of bacterial spices spirochete. The infections enter through the infected ticks that host in the human body and travel via the bloodstream and cause a wide range of symptoms depending upon the stages. The patient may experience fever, rash, arthritis, fatigue, headache and swollen lymph nodes. Rise in prevalence cases of lyme infected patients, widespread of domestic pet lover and increasing demands of available treatment are the drivers of market growth.

Lyme disease is an infection that is transmitted through the bite of a tick infected with a bacterium called Borrelia burgdorferi. Ticks typically get the bacterium by biting infected animals, like deer and mice. Most people who get tick bites do not get Lyme disease. Not all ticks are infected, and the risk for contracting the disease increases the longer the tick is attached to the body.

Global Lyme Disease Drug Market is expected to grow at a substantial CAGR in the forecast period of 2019-2026. An increase in prevalence cases of Lyme disease and accelerating demand for novel therapies may increase the market size.

Get Exclusive Sample Report: @ https://databridgemarketresearch.com/request-a-sample/?dbmr=global-lyme-disease-drug-market

Key Market Players:  Lyme Disease Drug Market

Sandoz International GmbH, Abbott, F. Hoffmann-La Roche, Canon U.S.A., T2 Biosystems, Lupin Pharmaceuticals, Mylan N.V, Sun Pharmaceutical Industries, Pfizer, Teva Pharmaceutical Industries, GlaxoSmithKline Plc (Valneva SE (Boehringer Ingelheim International GmbH, G&W Laboratories, Bio-Rad Laboratories, and among others.

The Lyme Disease Drug Market research report is a cautious examination which is gone for an in-depth comprehension of the course of the market. The point by point examination permits appraisal of the components impacting the market. Specialists have broken down the idea of advancement, interests in innovative work, changing utilization designs, and a developing number of uses. Furthermore, examiners have additionally assessed the changing financial matters around the market that are likely influencing its course. Investigators have examined the market drivers, controls, dangers, and openings present in the general market. The report shows course the market is relied upon to take in the coming a long time alongside its estimations.

Market Drivers

  • The rise in prevalence cases of Lyme infected patients
  • Widespread domestic pets lover as animals are the main carrier of this infection
  • Demands of available treatment and novel therapies

Market Restraints

  • Effective treatment is either unavailable or unaffordable
  • Patent expiry from many companies and the introduction of generic drugs is expected to restrain the growth if the market
  • Lack of awareness among the patient and physician about Lyme disease treatment

Table of Content: Global Lyme Disease Drug Market

Part 01: Executive Summary

Part 02: Scope of The Report

Part 03: Global Lyme Disease Drug Market Landscape

Part 04: Global Lyme Disease Drug Market Sizing

Part 05: Global Lyme Disease Drug Market Segmentation by Product

Part 06: Five Forces Analysis

Part 07: Customer Landscape

Part 08: Geographic Landscape

Part 09: Decision Framework

Part 10: Drivers and Challenges

Part 11: Market Trends

Part 12: Vendor Landscape

Part 13: Vendor Analysis

Continue…. For Detailed TOC Global Lyme Disease Drug Market Report at@   https://databridgemarketresearch.com/toc/?dbmr=global-lyme-disease-drug-market

Segmentation: Lyme Disease Drug Market

  • By Disease Type
    • Lyme carditis
    • Lyme arthritis
    • Neurologic Lyme disease
    • Borrelial lymphocytosis
    • Post-treatment Lyme Disease Syndrome
  • By Treatment Type
    • Medication
    • Tick removal
  • By Drug Type
    • Doxycycline
    • Cefuroxime axetil
    • Amoxicillin
    • Ceftriaxone and
    • Others
  • By Route of administration
    • Oral
    • Topical
    • Intravenous
  • By End-users
    • Hospitals
    • Homecare
    • Specialty Clinics
    • Others
  • By Geography
    • North America
      • US
      • Canada
      • Mexico
    • South America
      • Brazil
      • Argentina
      • Rest of South America
    • Europe
      • Germany
      • France
      • United Kingdom
      • Italy
      • Spain
      • Russia
      • Turkey
      • Belgium
      • Netherlands
      • Switzerland
      • Rest of Europe
    • Asia-Pacific
      • Japan
      • China
      • South Korea
      • India
      • Australia
      • Singapore
      • Thailand
      • Malaysia
      • Indonesia
      • Philippines
      • Rest of Asia Pacific
    • Middle East & Africa
      • South Africa
      • Egypt
      • Saudi Arabia
      • United Arab Emirates
      • Israel
      • Rest of Middle East & Africa

Key Developments in the Market:

  • On December 2018, Valneva SE has initiated Phase II trial for VLA15, a vaccine for the treatment of lyme infections.
  • On July 2017, Valneva SE received Fast Track designation from the FDA for VLA15, a vaccine for the treatment of lyme infections. VLA15 acts on the outer surface protein A (OspA) of Borrelia bacterium.

Want Full Report? Enquire Here @ https://databridgemarketresearch.com/inquire-before-buying/?dbmr=global-lyme-disease-drug-market

Competitive Analysis: Lyme Disease Drug Market

Global Lyme disease drug market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of Lyme disease market for Global, Europe, North America, Asia-Pacific, South America and Middle East & Africa.

Reasons to Purchase this Report

  • Current and future of global lyme disease drug market outlook in the developed and emerging markets
  • The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period
  • Regions/Countries that are expected to witness the fastest growth rates during the forecast period
  • The latest developments, market shares, and strategies that are employed by the major market players
Tags
Show More
Leave a Message
close slider

Close
Close